Foundayo dosage
The starting dosage is 0.8 mg orally once daily. The maximum dosage of FOUNDAYO is 17.2 mg once daily.
Word for word from the FDA label on DailyMed (Eli Lilly and Company), revised , version 10. Read every day: a new FDA version updates this page by itself.
Foundayo dosage chart
The soonest the label's schedule allows. A clinician can go slower.
| When | Dose |
|---|---|
| Days 1 to 30 | 0.8 mg |
| Days 31 to 60 | 2.5 mg |
| Day 61 on | 5.5 mg |
| Day 91 or later | 9 mgif needed and tolerated |
| Day 121 or later | 14.5 mgif needed and tolerated |
| Day 151 or later | 17.2 mgif needed and tolerated |
Foundayo dosing and administration
Recommended Dosage and Administration
Recommended Administration
- Take FOUNDAYO orally once daily, with or without food.
- Swallow tablets whole. Do not break, crush, or chew.
- Do not take more than one tablet per day.
Recommended Dosage Escalation
Follow the FOUNDAYO starting dosage and escalation described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions (5.3), Adverse Reactions (6)] .
- The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.
- After at least 30 days on the 2.5 mg dosage, increase the dosage to 5.5 mg once daily.
- The dosage may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily) after at least 30 days on the current dosage, based on treatment response and tolerability.
- The maximum dosage of FOUNDAYO is 17.2 mg once daily.
Dosage Modification for Concomitant Use with CYP3A4 Inhibitors and CYP3A4 Inducers
FOUNDAYO dosage modification may be required to manage interactions with some concomitant medications [see Drug Interactions (7.1), Clinical Pharmacology (12.3)] .
Strong CYP3A4 Inhibitors
- Avoid strong CYP3A4 inhibitors that also inhibit OATP1B when taking FOUNDAYO.
- The maximum dosage of FOUNDAYO is 9 mg once daily when used concomitantly with a strong CYP3A4 inhibitor [see Drug Interactions (7.1), Clinical Pharmacology (12.3)] .
Strong and Moderate CYP3A4 Inducers
- Avoid strong CYP3A4 inducers when taking FOUNDAYO.
- Monitor FOUNDAYO effectiveness when concomitantly using moderate CYP3A4 inducers and escalate FOUNDAYO dosage as needed [see Dosage and Administration (2.1, 2.3), Drug Interactions (7.1), Clinical Pharmacology (12.3)] .
Recommendations Regarding Missed Dose
- If a dose is missed, instruct patients to take the dose as soon as possible.
- Advise patients not to double up the next dose.
- If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions [see Dosage and Administration (2.1), Warnings and Precautions (5.3), Adverse Reactions (6)] .
Source: Foundayo prescribing information (FDA label on DailyMed), revised 2026-07-29
Foundayo strengths and forms
FOUNDAYO tablets are available as orforglipron:
- 0.8 mg: pink round tablet debossed with “L” on one side and “G1” on the other side
- 2.5 mg: light yellow round tablet debossed with “L” on one side and “G2” on the other side
- 5.5 mg: grayish purple round tablet debossed with “L” on one side and “G3” on the other side
- 9 mg: pink modified oval tablet debossed with “Lilly” on one side and “G4” on the other side
- 14.5 mg: light yellow modified oval tablet debossed with “Lilly” on one side and “G5” on the other side
- 17.2 mg: grayish purple modified oval tablet debossed with “Lilly” on one side and “G6” on the other side
Source: Foundayo prescribing information (FDA label on DailyMed), revised 2026-07-29
How to store Foundayo
How Supplied
FOUNDAYO (orforglipron) tablets are supplied in bottles with desiccant and child-resistant closure in cartons as follows:
| Tablet Strength of Orforglipron | Description | Package Configuration | NDC Number |
|---|---|---|---|
| 0.8 mg | Pink round tablet debossed with “L” on one side and “G1” on the other side | Bottles of 30 tablets | 0002-4178-31 |
| 2.5 mg | Light yellow round tablet debossed with “L” on one side and “G2” on the other side | Bottles of 30 tablets | 0002-4503-31 |
| 5.5 mg | Grayish purple round tablet debossed with “L” on one side and “G3” on the other side | Bottles of 30 tablets | 0002-4794-31 |
| 9 mg | Pink modified oval tablet debossed with “Lilly” on one side and “G4” on the other side | Bottles of 30 tablets | 0002-4803-31 |
| 14.5 mg | Light yellow modified oval tablet debossed with “Lilly” on one side and “G5” on the other side | Bottles of 30 tablets | 0002-4839-31 |
| 17.2 mg | Grayish purple modified oval tablet debossed with “Lilly” on one side and “G6” on the other side | Bottles of 30 tablets | 0002-4953-31 |
Storage and Handling
- Store FOUNDAYO at room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [See USP Controlled Room Temperature].
Source: Foundayo prescribing information (FDA label on DailyMed), revised 2026-07-29
Foundayo dosing: common questions
What should you expect in the first week of Foundayo?
From its FDA label: The starting dosage is 0.8 mg orally once daily. Your clinician may adjust this.
What is the starting dose of Foundayo?
The starting dosage is 0.8 mg orally once daily.
What is the maximum or maintenance dose of Foundayo?
The maximum dosage of FOUNDAYO is 17.2 mg once daily.
What if you miss a dose of Foundayo?
If a dose is missed, instruct patients to take the dose as soon as possible.
When should you take Foundayo?
Take FOUNDAYO orally once daily, with or without food.
How do you use Foundayo?
From its FDA-approved Medication Guide: Take FOUNDAYO exactly as your healthcare provider tells you to. Use FOUNDAYO with a reduced-calorie diet and increased physical activity. Take FOUNDAYO by mouth 1 time each day, with or without food. Swallow tablets whole. Do not break, crush, or chew the tablet. If you miss a dose, take it as soon as possible. Do not take 2 doses of FOUNDAYO in the same day. Do not take more than 1 tablet per day. If you miss taking FOUNDAYO for 7 or more days in a row, call your healthcare provider to talk about how to restart your treatment. If you take too much FOUNDAYO, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Dosing is decided by your clinician. This is the label's text for reference, not instructions for you.